Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Evaluation of WLBU2 peptide and 3-O-octyl-sn-glycerol lipid as active ingredients for a topical microbicide formulation targeting Chlamydia trachomatis.

Skinner MC, Kiselev AO, Isaacs CE, Mietzner TA, Montelaro RC, Lampe MF.

Antimicrob Agents Chemother. 2010 Feb;54(2):627-36. doi: 10.1128/AAC.00635-09. Epub 2009 Dec 14.

2.

Identification and evaluation of a combination of chlamydial antigens to support the diagnosis of severe and invasive Chlamydia trachomatis infections.

Forsbach-Birk V, Simnacher U, Pfrepper KI, Soutschek E, Kiselev AO, Lampe MF, Meyer T, Straube E, Essig A.

Clin Microbiol Infect. 2010 Aug;16(8):1237-44. doi: 10.1111/j.1469-0691.2009.03041.x. Epub 2009 Sep 1.

3.

Analysis of pmpD expression and PmpD post-translational processing during the life cycle of Chlamydia trachomatis serovars A, D, and L2.

Kiselev AO, Skinner MC, Lampe MF.

PLoS One. 2009;4(4):e5191. doi: 10.1371/journal.pone.0005191. Epub 2009 Apr 15.

4.
5.

Susceptibility of Chlamydia trachomatis to excipients commonly used in topical microbicide formulations.

Lampe MF, Rohan LC, Skinner MC, Stamm WE.

Antimicrob Agents Chemother. 2004 Aug;48(8):3200-2.

6.

Standardized test scores as an admission requirement.

Goodyear N, Lampe MF.

Clin Lab Sci. 2004 Winter;17(1):19-24.

PMID:
15011976
7.

Chlamydia trachomatis infection alters host cell transcription in diverse cellular pathways.

Xia M, Bumgarner RE, Lampe MF, Stamm WE.

J Infect Dis. 2003 Feb 1;187(3):424-34. Epub 2003 Jan 24.

PMID:
12552426
8.
9.

CD8+ T cells recognize an inclusion membrane-associated protein from the vacuolar pathogen Chlamydia trachomatis.

Fling SP, Sutherland RA, Steele LN, Hess B, D'Orazio SE, Maisonneuve J, Lampe MF, Probst P, Starnbach MN.

Proc Natl Acad Sci U S A. 2001 Jan 30;98(3):1160-5.

10.
11.

Susceptibility of Chlamydia trachomatis to chlorhexidine gluconate gel.

Lampe MF, Ballweber LM, Stamm WE.

Antimicrob Agents Chemother. 1998 Jul;42(7):1726-30.

12.

Killing of Chlamydia trachomatis by novel antimicrobial lipids adapted from compounds in human breast milk.

Lampe MF, Ballweber LM, Isaacs CE, Patton DL, Stamm WE.

Antimicrob Agents Chemother. 1998 May;42(5):1239-44.

16.
17.

Protective cytotoxic T lymphocytes are induced during murine infection with Chlamydia trachomatis.

Starnbach MN, Bevan MJ, Lampe MF.

J Immunol. 1994 Dec 1;153(11):5183-9.

PMID:
7525725
18.
19.

Long-term eradication of Chlamydia trachomatis genital infection after antimicrobial therapy. Evidence against persistent infection.

Workowski KA, Lampe MF, Wong KG, Watts MB, Stamm WE.

JAMA. 1993 Nov 3;270(17):2071-5. Erratum in: JAMA 1994 Feb 2;271(5):348.

PMID:
8305018
21.
22.

Cloning of the Bacillus subtilis recF gene.

Lampe MF, Bott KF.

Gene. 1985;38(1-3):139-44.

PMID:
3934046
23.

Cloning the gyrA gene of Bacillus subtilis.

Lampe MF, Bott KF.

Nucleic Acids Res. 1984 Aug 10;12(15):6307-23.

24.

Mutational enzymatic resistance of Enterobacter species to beta-lactam antibiotics.

Lampe MF, Allan BJ, Minshew BH, Sherris JC.

Antimicrob Agents Chemother. 1982 Apr;21(4):655-60.

25.

In vitro response of Enterobacter to ampicillin.

Lampe MF, Minshew BH, Sherris JC.

Antimicrob Agents Chemother. 1979 Oct;16(4):458-62.

26.

Reproducibility of control strains for antibiotic susceptibility testing.

Coyle MB, Lampe MF, Aitken CL, Feigl P, Sherris JC.

Antimicrob Agents Chemother. 1976 Sep;10(3):436-40.

27.

Relationship of early readings of minimal inhibitory concentrations to the results of overnight tests.

Lampe MF, Aitken CL, Dennis PG, Forsythe PS, Patrick KE, Schoenknecht FD, Sherris JC.

Antimicrob Agents Chemother. 1975 Oct;8(4):429-33.

Supplemental Content

Loading ...
Support Center